Ranbaxy Laboratories (Delisted) MD, chairman, board of directors and AGM
BSE: 500359
Last traded ₹859.80 on 1 Apr 2015
Delisted on 30 Mar 2016.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 19 Sep 2014, 4 fund houses
- Approval for Scheme of Arrangement between Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Limited1 for0 against
- Scheme of arrangement between Sun Pharmaceutical Industries Ltd (Sun Pharma) and Ranbaxy Laboratories Ltd (Ranbaxy)1 for0 against
the Scheme of Arrangement between Ranbaxy Laboratories Limited and Sun Pharmaceutical Industries Limited as placed before the meeting and, for the purpose of identification, initialed by the Chairman of the meeting be and is hereby approved subject to the said Scheme of Arrangement being sanctioned by the Hon’ble High Court of Punjab and Haryana at Chandigarh under Sections 391-394 and other applicable provisions, if any, of the Companies Act, 1956 and such other approvals as may be required.MoreLess
1 for0 againstThe Scheme of Arrangement between Ranbaxy Laboratories Limited (Transferor Company) and Sun Pharmaceutical Industries Limited (Transferee Company) as placed before the meeting and, for the purpose of identification, initialed by the Chairman of the meeting be and is hereby approved subject to the said Scheme of Arrangement being sanctioned by the Hon’ble High Court of Punjab and Haryana at Chandigarh under Sections 391-394 and other applicable provisions, if any, of the Companies Act, 1956 and such other approvals as may be required.MoreLess
0 for0 against1 abstained
Mutual fund votes, meeting of 28 Jul 2014, 3 fund houses
- Appointment of Dr. Anthony H. Wild as an Independent Director of the Company for a period of 5 yrs.1 for0 against
- Appointment of M/s. BSR & Co. LLP, (Registeration no: 101248W) as the Auditors of the Company and fixation of remuneration1 for0 against
- Appointment of Mr. Akihiro Watanabe as an Independent Director of the Company for a period of 5 yrs.1 for0 against
- Appointment of Mr. Percy K. Shroff as an Independent Director of the Company for a period of 5 yrs.1 for0 against
- Appointment of Mr. Rajesh V. Shah as an Independent Director of the Company for a period of 5 yrs.1 for0 against
- Approval for payment of revised remuneration to Mr. Arun Sawhney, CEO & Managing Director of the Company effective April 1, 2014 for the remaining tenure of his appointment i.e. December 31, 2016.1 for0 against
- Approve report with regards to erosion of peak net worth1 for0 against
Authorise Board of Directors of the Company to borrow monies together with monies already borrowed by the Company upto Rs.7,500 Crores as outstanding at any time in excess of the aggregate of Paid-up Capital and Free Reserves of the Company from time to timeMoreLess
1 for0 againstConsent of the Company be & hereby accorded for the nomination of Mr. Rajesh V Shah, Dr. Anthony H Wild, Mr. Percy K Shroff & Mr. Akihiro Wantanabe as an Independent Director on the Board of the major overseas subsidiaries of the Company and fixation of remuneration from the respective subsidiary Company by way of profit related commissionMoreLess
1 for0 against- Consent of the Company be & hereby accorded for the payment of remuneration to the Non Executive Directors of the Company1 for0 against
- Consideration of the Balance Sheet, Profit & Loss Account and the Report of Directors and Auditors thereon for the year ended on 31.03.20141 for0 against
- Dr. Anthony H Wild, be and is hereby appointed as an independent Director of the Company,to hold office for 5 years wef April 1, 2014 , not laible to retire by rotation1 for0 against
- Fix remuneration of of non-executive non-independent and independent directors for FY151 for0 against
- Increase in the borrowing limits of the Company upto Rs. 7,500 crore1 for0 against
- Mr. Akihiro Watanabe, be and is hereby appointed as an independent Director of the Company, to hold office for 5 years wef April 1, 2014 ,not laible to retire by rotation1 for0 against
- Mr. Percy K Shroff, be and is hereby appointed as an independent Director of the Company, to hold office for 5 years wef April 1, 2014 , not laible to retire by rotation1 for0 against
- Mr. Rajesh V Shah, be and is hereby appointed as an independent Director of the Company,to hold office for 5 years wef April 1, 2014 , not laible to retire by rotation1 for0 against
- Nomination of independent directors as a director on board of major overseas subsidiaries1 for0 against
- Nomination of Independent Directors of the Company as Directors on the Board of the major overseas subsidiaries of the Company1 for0 against
- Payment of remuneration to the Non-Executive Directors of Company1 for0 against
Pursuant to the provisions of Section 23 and other applicable provisions of the Sick Industrial Companies (Special Provisions) Act, 1985 (SICA), the Report of Board of Directors of the Company, for considering causes of erosion of more than 50% of the Company’s peak net worth during immediately preceding four financial years as on March 31, 2014 and the steps being taken by the Company in this regard, be and is hereby approvedMoreLess
1 for0 against- Re-appointment of M/s. R.J. Goel & Co., Cost Accountants as Cost Auditors of the Company for FY 2014-151 for0 against
- Re-appointment of M/s RJ Goel & Co , Cost Accountants as Cost Auditors of the Company, to audit the Cost accounts of the Company for the year 2014-15 & to fix their remuneration1 for0 against
- Revision in remuneration of Mr. Arun Sawhney, CEO & Managing Director of the Company w.e.f. April 1, 20141 for0 against
- Revision of remuneration to Mr. Arun Sawhney, CEO-MD for period from 1Apr2014 to 31Dec20161 for0 against
- To appoint a Director in place of Mr.Takashi Shoda(DIN: 02436813) who retires by rotation and being eligible offers himself for re-appointment.1 for0 against
- To approve action taken by the company under1 for0 against
- To re-appoint Akihiro Watanabo as an Independent Director of the company for a period of 5 years with effect from 01st April, 20141 for0 against
- To re-appoint Dr. Anthony H. Wilde as an Independent Director of the company for a period of 5 years with effect from 01st April, 20141 for0 against
To re-appoint M/S B S R & Co, as Auditors of the Company to hold office from the conclusion of this Meeting until the conclusion of the next Annual General Meeting of the Company and to authorise the Audit Committee to fix their remuneration.MoreLess
1 for0 against- To re-appoint M/s R J Goel & Co as cost auditors1 for0 against
- To re-appoint Mr. Percy K. Shroff as an Independent Director of the company for a period of 5 years with effect from 01st April, 20141 for0 against
- To re-appoint Mr. Rajesh V Shah as an Independent Director of the company for a period of 5 years with effect from 01st April, 20141 for0 against
- To re-appoint Takashi Shoda as Director, who retires by rotation1 for0 against
- To receive, consider and adopt the Profit and Loss Account for the 15 months period ended March 31, 2014 and the Balance Sheet as at the date and the reports of the directors and the auditors there.1 for0 against
- To reconfirm authority to the Board of Directors for borrowing money upto 7,500 Crores1 for0 against
1 earlier meeting
Mutual fund votes, meeting of 7 May 2013, 1 fund house
- Appointment of Dr Kazunori Hirokawa as Director.0 for0 against
1 abstained
- Consideration of the Balance Sheet, Profit & Loss Account and the report of Directors and Auditors thereon for the year ended on 31.12.2012.0 for0 against
1 abstained
- Payment of remuneration to Dr Kazunori Hirokawa as Non executive Director w.e.f. 09.05.2012 to 31.12.2012 and for the year 2013.0 for0 against
1 abstained
- Re-appointment of Dr Tsutomu Une and Mr Rajesh V Shah as Directors.0 for0 against
1 abstained
- Re-appointment of M/s B S R & Co., as Auditors and to fix their remuneration for the next Annual General Meeting.0 for0 against
1 abstained
Each fund house counted once, from its own disclosure; the reasons are its own words.